[Biologic availability of digoxin in soft gelatin capsules and in tablets]. 1974

G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti

UI MeSH Term Description Entries
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
April 1973, JAMA,
G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
January 1978, Bollettino della Societa italiana di cardiologia,
G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
July 1981, Il Farmaco; edizione pratica,
G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
January 1979, Arzneimittel-Forschung,
G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
October 2010, Journal of pharmaceutical sciences,
G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
September 1977, The Journal of pharmacy and pharmacology,
G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
March 1978, Vnitrni lekarstvi,
G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
July 2003, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
January 1979, British journal of clinical pharmacology,
G C Merotti, and P Ghirardi, and A Marzo, and M A Parenti
January 2003, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
Copied contents to your clipboard!